Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug

Clinical trial NCT00043901 · COMPLETED

Trial details

NCT number: NCT00043901
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Epilepsy, Tonic-Clonic

Start date: 2000-12-01
Primary completion: 2003-11-01
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.